Mineralys Therapeutics, Inc.
HealthcareNASDAQ:MLYS · NASDAQ Global Select
-$0.32 today
Vol 1.80M · Avg 1.46M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+64.94%
Period High
$47.33
Period Low
$12.87
Latest
$23.62
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Cidara Therapeutics, Inc.
CDTX
$5.61B
Scholar Rock Holding Corporation
NASDAQ:SRRK
$5.29B
Apellis Pharmaceuticals, Inc.
APLS
$5.25B
Catalyst Pharmaceuticals, Inc.
NASDAQ:CPRX
$3.84B
Beam Therapeutics Inc.
NASDAQ:BEAM
$2.99B
Adaptive Biotechnologies Corporation
NASDAQ:ADPT
$2.82B
IDEAYA Biosciences, Inc.
NASDAQ:IDYA
$2.55B
Zai Lab Limited
NASDAQ:ZLAB
$1.92B
Agios Pharmaceuticals, Inc.
NASDAQ:AGIO
$1.75B
Recursion Pharmaceuticals, Inc.
NASDAQ:RXRX
$1.41B
What is the latest MLYS filing?
The latest filing shown is 4 dated Jun 12, 2026.
How many recent filings does MLYS have?
Intrinsic Alpha currently shows 20 recent filings for MLYS.
Explore More
Continue the stock analysis
Jump to another research area for this company.